A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia

American Journal of Geriatric Psychiatry

Volumn 5, Issue 1, 1997, Pages 60-69

  Sultzer, David L ^a   Gray, Kevin F ^b   Gunay, Ibrahim ^b   Berisford, M Andrew ^b   Mahler, Michael E ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; TRAZODONE;

ADULT; AGED; AGGRESSION; AGITATION; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DEMENTIA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; HUMAN; MYALGIA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; RASH; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0031026215     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-199705010-00008     Document Type: Article

References (55)

1. Cohen-Mansfield J: Agitated behaviors in the elderly, I: a conceptual review. J Am Geriatr Soc 1986; 34:711-721
2. Cummings JL, Victoroff JI: Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1990; 3:140-158
3. Devanand DP, Brockington CD, Moody BJ, et al: Behavioral syndromes in Alzheimer's disease. Int Psychogeriatr 1992; 4:161-184
4. Reisberg B, Borenstein J, Salob SP, et al: Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48(suppl 5):9-15
5. Sultzer DL, Levin HS, Mahler ME, et al: Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. J Am Geriatr Soc 1992; 40:549-555
6. Tariot PN, Podgorski CA, Blazina L, et al: Mental disorders in the nursing home: another perspective. Am J Psychiatry 1993; 150:1063-1069
7. Cohen-Mansfield J, Marx MS, Rosenthal AS: A description of agitation in a nursing home. J Gerontol 1989; 44:M77-M84
8. Rovner BW, Kafonek S, Filipp L, et al: Prevalence of mental illness in a community nursing home. Am J Psychiatry 1986; 143:1446-1449
9. Draper BM, Poulos CJ, Cole AMD, et al: A comparison of caregivers for elderly stroke and dementia victims. J Am Geriatr Soc 1992; 40:896-901
10. Gallagher-Thompson D, Brooks JO, Bliwise D, et al: The relations among caregiver stress, "sundowning" symptoms, and cognitive decline in Alzheimer's disease. J Am Geriatr Soc 1992; 40:807-810
11. Chui HC, Lyness SA, Sobel E, et al: Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol 1994; 51:676-681
12. Mortimer JA, Ebbitt B, Jun S-P, et al: Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992; 42:1689-1696
13. Gold DP, Reis MF, Markiewicz D, et al: When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia. J Am Geriatr Soc 1995; 43:10-16
14. Steele C, Rovner B, Chase GA, et al: Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990; 147:1049-1051
15. Coyne AC, Reichman WE, Berbig LJ: The relationship between dementia and elder abuse. Am J Psychiatry 1993; 150:643-646
16. Bridges-Parlet S, Knopman D, Thompson T: A descriptive study of physically aggressive behavior in dementia by direct observation. J Am Geriatr Soc 1994; 42:192-197
17. Malone ML, Thompson L, Goodwin JS: Aggressive behaviors among the institutionalized elderly. J Am Geriatr Soc 1993; 41:853-856
18. Zubenko GS, Rosen J, Sweet RA, et al: Impact of psychiatric hospitalization on behavioral complications of Alzheimer's disease. Am J Psychiatry 1992; 149:1484-1491
19. Kunik ME, Yudofsky SC, SilverJM, et al: Pharmacologic approach to management of agitation associated with dementia. J Clin Psychiatry 1994; 55:13-17
20. Teri L, Logsdon R: Assessment and management of behavioral disturbances in Alzheimer's disease. Compr Ther 1990; 16:36-42
21. Semla TP, Cohen D, Paveza G, et al: Drug use patterns of persons with Alzheimer's disease and related disorders living in the community. J Am Geriatr Soc 1993; 41:408-413
22. Schneider LS, Pollock VE, Lyness SA: A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563
23. Sunderland T, Silver M: Neuroleptics in the treatment of dementia. International Journal of Geriatric Psychiatry 1988; 3:79-88
24. Dysken MW, Johnson SB, Holden L, et al: Haloperidol concentrations in patients with Alzheimer's disease. American Journal of Geriatric Psychiatry 1994; 2:124-133
25. Coccaro EF, Kramer E, Zemishlany Z, et al: Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am J Psychiatry 1990; 147:1640-1645
26. Schneider LS, Sobin PB: Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia. Psychopharmacol Bull 1992; 28:71-79
27. Tariot PN, Erb R, Leibovici A, et al: Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994; 42:1160-1166
28. Salzman C, Vaccaro B, Lieff J, et al: Clozapine in older patients with psychosis and behavioral disruption. American Journal of Geriatric Psychiatry 1995; 3:26-33
29. Pinner E, Rich CL: Effects of trazodone on aggressive behavior in seven patients with organic mental disorders. Am J Psychiatry 1988; 145:1295-1296
30. Schneider LS, Gleason RP, Chui HC: Progressive supranuclear palsy with agitation: response to trazodone but not to thiothixine or carbamazepine. J Geriatr Psychiatry Neurol 1989; 2:109-112
31. Houlihan DJ, Mulsant BH, Sweet RA, et al: A naturalistic study of trazodone in the treatment of behavioral complications of dementia. American Journal of Geriatric Psychiatry 1994; 2:78-85
32. Wilcock GK, Stevens J, Perkins A: Trazodone/tryptophan for aggressive behaviour. Lancet 1987; 1:929-930
33. Tingle D: Trazodone in dementia. J Clin Psychiatry 1986; 47:482-483
34. Greenwald BS, Marin DB, Silverman SM: Serotonergic treatment of screaming and banging in dementia. Lancet 1986; 2:1486-1487
35. Simpson DM, Foster D: Improvement in organically disturbed behavior with trazodone treatment. J Clin Psychiatry 1986; 47:191-193
36. Lebert F, Pasquier F, Petit H: Behavioral effects of trazodone in Alzheimer's disease. J Clin Psychiatry 1994; 55:536-538
37. Finkel SI, Lyons JS, Anderson RL: Reliability and validity of the Cohen-Mansfield Agitation Inventory in institutionalized elderly. International Journal of Geriatric Psychiatry 1992; 7:487-490
38. 38.American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, Revised. Washington, DC, American Psychiatric Association, 1987
39. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology. Washington, DC, U.S. Department of Health, Education, and Welfare, 1976
40. Yudofsky SC, Silver JM, Jackson W, et al: The Oven Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986; 143:35-39
41. Folstein M, Folstein S, McHugh P: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
42. Barnes TRE: A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154:672-676
43. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
44. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260
45. Risse SC, Lampe TH, Cubberley L: Very-low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease. J Clin Psychiatry 1987; 48:207-208
46. Lohr JB, Jeste DV, Harris MJ, et al: Treatment of disordered behavior, in Clinical Geriatric Psychopharmacology. Edited by Salzman C. Baltimore, MD, Williams & Wilkins, 1992, pp 79-113
47. Devanand D: Atypical and typical neuroleptics: use and monitoring in the nursing home. Presented at the 9th Annual Meeting of the American Association for Geriatric Psychiatry, Tucson, AZ, February, 1996
48. Borison RL, Diamond BI: Neuropharmacology of the extrapyramidal system. J Clin Psychiatry 1987; 48(suppl 9):7-12
49. Haria M, Fitton A, McTavish D: Trazodone: a review of its pharmacology, therapeutic use in depression, and therapeutic potential in other disorders. Drugs Aging 1994; 4:331-355
50. Brown GL, Linnoila MI: CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry 1990; 51:31-41
51. Mann JJ: Violence and aggression, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven, 1995, pp 1919-1928
52. Higley JD, Mehlman PT, Taub DM, et al: Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch Gen Psychiatry 1992; 49:436-441
53. Coccaro EF, Siever LJ, Klar HM, et al: Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989; 46:587-599
54. Linnoila VMI, Virkkunen M: Aggression, suicidality, and serotonin. J Clin Psychiatry 1992; 53(suppl 10):46-51
55. Virkkunen M, Rawlings R, Tokola R, et al: CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire-setters, and healthy volunteers. Arch Gen Psychiatry 1994; 51:20-27